Related Experiment Video

Updated: Mar 2, 2026

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
04:41

Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

Published on: July 3, 2018

8.7K

microRNAs in ischaemic cardiovascular diseases

Simona Greco1, Germana Zaccagnini1, Christine Voellenkle1

  • 1Molecular Cardiology Laboratory, IRCCS Policlinico San Donato, via Morandi 30, 20097 San Donato Milanese, Milan, Italy.

European Heart Journal Supplements : Journal of the European Society of Cardiology
|May 24, 2017
PubMed

Insights

MicroRNAs (miRNAs) regulate gene expression and are crucial in cardiovascular diseases. Studies show miRNAs play a key role in cellular responses to hypoxia and ischemic conditions, highlighting their therapeutic potential.

Area of Science:

  • Molecular Biology
  • Cardiovascular Research
  • Genetics

Background:

  • MicroRNAs (miRNAs) are non-coding RNA regulators impacting gene expression.
  • miRNA dysregulation is implicated in various cardiovascular diseases.
  • Cardiovascular research increasingly focuses on miRNA's role in disease pathogenesis.

Purpose of the Study:

  • To review studies on miRNA function in cardiovascular diseases.
  • To investigate the role of miRNAs in cellular response to hypoxia.
  • To explore miRNA as a therapeutic target for ischemic cardiovascular diseases.

Main Methods:

  • Review of studies conducted at Policlinico San Donato-IRCCS.
  • Analysis of data from cell cultures, animal models, and human patients.
  • Examination of miRNA expression and function in disease contexts.

Main Results:

  • miRNAs demonstrate a significant role in cellular responses to hypoxia.
  • miRNAs are critically involved in the pathophysiology of ischemic cardiovascular diseases.
  • Evidence supports the involvement of specific miRNAs in disease progression.

Conclusions:

  • MicroRNAs are key regulators in cardiovascular pathophysiology, particularly in hypoxia and ischemia.
  • miRNAs represent a promising and emerging class of therapeutic targets for cardiovascular diseases.
  • Further research into miRNA-based therapies is warranted for treating ischemic heart conditions.
Keywords:
Cardiovascular diseasesHypoxiaIschaemiamicroRNA

More Related Videos

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge09:53

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

8.0K
Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice05:07

Author Spotlight: Improved Localization and Monitoring of Coronary Flow Reserve Using Modified PLAX View in Mice

Published on: August 25, 2023

2.1K

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
826